Proactive screening
Reveal how your patient's genes could impact their health, enabling proactive monitoring and preventive care before conditions develop.
sequence once, query often®
TURNAROUND
Existing Patient (SOQO)Ⓡ≤ 21 days
TURNAROUND
New Patient14-28 days
SAMPLE
Saliva, Blood, Buccal
One comprehensive test provides clinical answers today and enables future queries as science evolves.
Clinical Utility
Identifies individuals with actionable hereditary conditions who may benefit from:
- Earlier or more frequent health screening
- Risk-reducing medical management
- Targeted or preventive treatments
- Clarification of risk for family members
TECH SPECS
Methodology
Exome+® NGS (exome capture + deep intronic coverage in key regions + relevant promoters and inversions).
Accuracy
> 99.9% analytical sensitivity for SNVs and small indels.
CNV resolution
Single exon-level resolution for deletions and duplications.
Wayfinder™ interpretation
Automated pathogenicity score recommendations powered by AI intelligence, augmented by > 850k longitudinal records.
Test Catalog
Select a test below to view a detailed test description, technical specifications and complete gene list.
Tier One Population Screen
An 11-gene screening test for hereditary breast and ovarian cancer (HBOC), Lynch syndrome, and familial hypercholesterolemia, powered by the Helix Exome+® platform.
11
genesHereditary Actionable Disorders Screen
An 89-gene screening test for hereditary predisposition to cancer, cardiac disease, metabolic, muscular, and blood clotting disorders, powered by the Helix Exome+® platform.
89
genesHereditary Cancer Screen
A 48-gene screening test for hereditary cancer predisposition across breast, gynecologic, prostate, and gastrointestinal systems, powered by the Helix Exome+® platform.
48
genes